$PED
PEDEVCO CORP Stock $ped

$ped Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424006414 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$11.81M	$8.116M
YoY Change	8.26%	-0.59%
Cost Of Revenue	$3.548M	$2.531M
YoY Change	26.31%	2.64%
Gross Profit	$8.263M	$5.585M
YoY Change	2.0%	-1.98%
Gross Profit Margin	69.96%	68.81%
Selling, General & Admin	$1.383M	$1.495M
YoY Change	3.83%	0.47%
% of Gross Profit	16.74%	26.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.242M	$3.485M
YoY Change	31.13%	35.03%
% of Gross Profit	51.34%	62.4%
Operating Expenses	$9.173M	$7.511M
YoY Change	24.36%	14.93%
Operating Profit	$2.638M	$617.0K
YoY Change	-25.35%	-62.12%
Interest Expense	$93.00K	$149.0K
YoY Change	8.14%	52.04%
% of Operating Profit	3.53%	24.15%
Other Income/Expense, Net	$43.00K	$10.00K
YoY Change	-50.0%	-92.48%
Pretax Income	$2.681M	$773.0K
YoY Change	-25.94%	-56.13%
Income Tax
% Of Pretax Income
Net Earnings	$2.681M	$773.0K
YoY Change	-25.94%	-56.13%
Net Earnings / Revenue	22.7%	9.52%
Basic Earnings Per Share	$0.03	$0.01
Diluted Earnings Per Share	$0.03	$0.01
COMMON SHARES
Basic Shares Outstanding	89.36M shares	89.36M shares
Diluted Shares Outstanding	89.33M shares	88.75M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.132M	$13.29M
YoY Change	-50.8%	-5.98%
Cash & Equivalents	$6.132M	$13.29M
Short-Term Investments
Other Short-Term Assets	$135.0K	$196.0K
YoY Change	170.0%	31.54%
Inventory
Prepaid Expenses
Receivables	$8.627M	$6.735M
Other Receivables	$172.0K	$106.0K
Total Short-Term Assets	$15.07M	$20.33M
YoY Change	-20.52%	1.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$92.03M	$94.42M
YoY Change	5.78%	12.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.874M	$2.487M
YoY Change	-24.74%	-34.91%
Total Long-Term Assets	$95.92M	$97.96M
YoY Change	5.62%	11.25%
TOTAL ASSETS
Total Short-Term Assets	$15.07M	$20.33M
Total Long-Term Assets	$95.92M	$97.96M
Total Assets	$111.0M	$118.3M
YoY Change	1.1%	9.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.727M	$12.06M
YoY Change	69.48%	227.56%
Accrued Expenses	$1.581M	$1.280M
YoY Change	19.59%	-6.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.127M	$15.54M
YoY Change	25.91%	129.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.703M	$2.743M
YoY Change	-4.35%	4.38%
Total Long-Term Liabilities	$2.703M	$2.743M
YoY Change	-4.35%	4.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.127M	$15.54M
Total Long-Term Liabilities	$2.703M	$2.743M
Total Liabilities	$7.830M	$18.28M
YoY Change	13.51%	94.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.0M	-$125.7M
YoY Change	1.37%	0.58%
Common Stock	$89.00K	$89.00K
YoY Change	2.3%	2.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$103.2M	$100.0M
YoY Change
Total Liabilities & Shareholders Equity	$111.0M	$118.3M
YoY Change	1.1%	9.4%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$2.681M	$773.0K
YoY Change	-25.94%	-56.13%
Depreciation, Depletion And Amortization	$4.242M	$3.485M
YoY Change	31.13%	35.03%
Cash From Operating Activities	$4.590M	-$4.295M
YoY Change	-30.37%	-341.02%
INVESTING ACTIVITIES
Capital Expenditures	$11.41M	$938.0K
YoY Change	37.98%	-94.51%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$12.00K
YoY Change
Cash From Investing Activities	-$11.41M	-$926.0K
YoY Change	37.98%	-94.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	4.590M	-$4.295M
Cash From Investing Activities	-11.41M	-$926.0K
Cash From Financing Activities
Net Change In Cash	-6.817M	-$5.221M
YoY Change	306.99%	-65.86%
FREE CASH FLOW
Cash From Operating Activities	$4.590M	-$4.295M
Capital Expenditures	$11.41M	$938.0K
Free Cash Flow	-$6.817M	-$5.233M
YoY Change	306.99%	-65.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	147000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	2531000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2466000	usd
CY2024Q1	ped	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P2Y10M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0790	pure
CY2024Q1	us-gaap	Other Commitments Description OtherCommitmentsDescription	In the D-J Basin, no net acres expire during the remainder of 2024, and 5,829 net acres expire within the next two-year period (net to our direct ownership interest only). In the Permian Basin, 40 net acres are due to expire during the remainder of 2024 and no net acres expire within the next two-year period (net to our direct ownership interest only)
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1495000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3485000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2581000	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001141197
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87250267	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89355267	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-35922
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	PEDEVCO CORP.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3755993
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	575 N. Dairy Ashford
CY2024Q1	dei	Trading Symbol TradingSymbol	PED
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
CY2024Q1	dei	City Area Code CityAreaCode	713
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	221-1768
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	89355267	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13294000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18515000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	6735000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	5790000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	106000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	42000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	196000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	260000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	20331000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	24607000	usd
CY2024Q1	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	87538000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	79186000	usd
CY2024Q1	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	6584000	usd
CY2023Q4	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	12407000	usd
CY2024Q1	us-gaap	Mineral Properties Net MineralPropertiesNet	94122000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	91593000	usd
CY2024Q1	ped	Receivables Net Non Current ReceivablesNetNonCurrent	1062000	usd
CY2023Q4	ped	Receivables Net Non Current ReceivablesNetNonCurrent	1099000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	293000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2487000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2443000	usd
CY2024Q1	us-gaap	Assets Assets	118295000	usd
CY2023Q4	us-gaap	Assets Assets	120058000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12064000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6580000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1280000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8712000	usd
CY2024Q1	ped	Revenue Payable Current RevenuePayableCurrent	1918000	usd
CY2023Q4	ped	Revenue Payable Current RevenuePayableCurrent	3371000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	91000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	185000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15538000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18899000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	204000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	227000	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2539000	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2166000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	18281000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	21292000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	89000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	87000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225629000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225156000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-125704000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126477000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	100014000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	98766000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118295000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120058000	usd
CY2024Q1	us-gaap	Revenues Revenues	8116000	usd
CY2023Q1	us-gaap	Revenues Revenues	8164000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1488000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	7511000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6535000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	12000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	617000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1629000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	149000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	98000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	7000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	35000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	156000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	133000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	773000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	88753838	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86720823	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88753838	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86720823	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	773000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1762000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3485000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2581000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	475000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	518000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	945000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3358000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	12000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	27000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-64000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-100000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6621000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	136000	usd
CY2024Q1	ped	Increase Decrease In Revenue Payable IncreaseDecreaseInRevenuePayable	-1453000	usd
CY2023Q1	ped	Increase Decrease In Revenue Payable IncreaseDecreaseInRevenuePayable	-18000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4295000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1782000	usd
CY2024Q1	ped	Payments To Acquire Drilling And Completion Costs PaymentsToAcquireDrillingAndCompletionCosts	883000	usd
CY2023Q1	ped	Payments To Acquire Drilling And Completion Costs PaymentsToAcquireDrillingAndCompletionCosts	17032000	usd
CY2024Q1	ped	Cash Received For Sale Of Vehicle CashReceivedForSaleOfVehicle	12000	usd
CY2023Q1	ped	Cash Received For Sale Of Vehicle CashReceivedForSaleOfVehicle	0	usd
CY2024Q1	ped	Payments To Purchase Vehicle PaymentsToPurchaseVehicle	55000	usd
CY2023Q1	ped	Payments To Purchase Vehicle PaymentsToPurchaseVehicle	41000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-926000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17073000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5221000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-15291000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20715000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32977000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15494000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17686000	usd
CY2024Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q1	ped	Change In Accrued Oil And Gas Development Costs ChangeInAccruedOilAndGasDevelopmentCosts	-4709000	usd
CY2023Q1	ped	Change In Accrued Oil And Gas Development Costs ChangeInAccruedOilAndGasDevelopmentCosts	10534000	usd
CY2024Q1	ped	Changes In Estimates Of Asset Retirement Costs Net ChangesInEstimatesOfAssetRetirementCostsNet	102000	usd
CY2023Q1	ped	Changes In Estimates Of Asset Retirement Costs Net ChangesInEstimatesOfAssetRetirementCostsNet	6000	usd
CY2024Q1	ped	Proceeds From Issuance Of Restricted Common Stock ProceedsFromIssuanceOfRestrictedCommonStock	2000	usd
CY2023Q1	ped	Proceeds From Issuance Of Restricted Common Stock ProceedsFromIssuanceOfRestrictedCommonStock	1000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	98766000	usd
CY2024Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	475000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	773000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	100014000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	518000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98739000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8116000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8164000	usd
CY2024Q1	us-gaap	Cash Cash	13294000	usd
CY2023Q4	us-gaap	Cash Cash	18515000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2200000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2200000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	15494000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	20715000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	185403000	usd
CY2024Q1	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	196818000	usd
CY2023Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	12407000	usd
CY2024Q1	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	6584000	usd
CY2023Q4	ped	Asset Retirement Costs AssetRetirementCosts	853000	usd
CY2024Q1	ped	Asset Retirement Costs AssetRetirementCosts	955000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	107070000	usd
CY2024Q1	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	110235000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	91593000	usd
CY2024Q1	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	94122000	usd
CY2024Q1	ped	Capital Costs Incurred Recently Completed Wells CapitalCostsIncurredRecentlyCompletedWells	5362000	usd
CY2024Q1	ped	Description Of Additional Paid DescriptionOfAdditionalPaid	The Company also acquired approximately 407 net lease acres, in and around its existing footprint in the D-J Basin, through multiple transactions with total acquisition and due diligence costs of $230,000
CY2024Q1	us-gaap	Depletion Depletion	3165000	usd
CY2023Q1	us-gaap	Depletion Depletion	2447000	usd
CY2024Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.100	pure
CY2024Q1	ped	Note In Current Assets NoteInCurrentAssets	106000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	1062000	usd
CY2024Q1	ped	Accrued Interest AccruedInterest	46000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2313000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	309000	usd
CY2024Q1	ped	Changes In Estimates ChangesInEstimates	102000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2724000	usd
CY2023Q4	ped	Cureent Asset Retirement CureentAssetRetirement	147000	usd
CY2024Q1	ped	Cureent Asset Retirement CureentAssetRetirement	185000	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	10000	usd
CY2024Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2027-02-28
CY2024Q1	ped	Monthly Rent MonthlyRent	9200	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	14700	usd
CY2024Q1	us-gaap	Prepaid Rent PrepaidRent	14700	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	293000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	91000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	204000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	295000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	83000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	112000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	115000	usd
CY2024Q1	ped	Lessee Operating Lease Liability Payments Due Thereafter LesseeOperatingLeaseLiabilityPaymentsDueThereafter	19000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	329000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	34000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	295000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2105000	shares
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	401000	usd
CY2024Q1	ped	Unamortized Stock Based Compensation Expense Restricted Stock Option UnamortizedStockBasedCompensationExpenseRestrictedStockOption	1844000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	460000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.6775
CY2023Q1	us-gaap	Contract Termination Claims Description ContractTerminationClaimsDescription	The options have a term of five years and fully vest in January 2027, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	216000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.0404	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.04	pure
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	74000	usd
CY2024Q1	ped	Intrinsic Value Of Outstanding And Exercisable Options IntrinsicValueOfOutstandingAndExercisableOptions	57000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1632334	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	460000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.68
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2092334	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.14
CY2024Q1	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P3Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1122334	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.35
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	773000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2024Q1	ped	Effect Of Common Stock Equivalents EffectOfCommonStockEquivalents	0	usd
CY2023Q1	ped	Effect Of Common Stock Equivalents EffectOfCommonStockEquivalents	0	usd
CY2024Q1	ped	Net Income Adjusted For Common Stock Equivalents NetIncomeAdjustedForCommonStockEquivalents	773000	usd
CY2023Q1	ped	Net Income Adjusted For Common Stock Equivalents NetIncomeAdjustedForCommonStockEquivalents	1762000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88753838	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86720823	shares
CY2024Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88753838	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86720823	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2024Q1	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	2092334	shares
CY2023Q1	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1926001	shares

Files In Submission

Name	View Source	Status
0001654954-24-006414-index-headers.html	Edgar Link	pending
0001654954-24-006414-index.html	Edgar Link	pending
0001654954-24-006414.txt	Edgar Link	pending
0001654954-24-006414-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ped-20240331.xsd	Edgar Link	pending
ped_10q.htm	Edgar Link	pending
ped_10qimg2.jpg	Edgar Link	pending
ped_ex311.htm	Edgar Link	pending
ped_ex312.htm	Edgar Link	pending
ped_ex321.htm	Edgar Link	pending
ped_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ped-20240331_cal.xml	Edgar Link	unprocessable
ped-20240331_def.xml	Edgar Link	unprocessable
ped-20240331_lab.xml	Edgar Link	unprocessable
ped-20240331_pre.xml	Edgar Link	unprocessable
ped_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PED
PEDEVCO CORP Stock $ped

2024 Q2 Form 10-Q Financial Statement

#000165495424006414 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED PEDEVCO CORP Stock $ped

2024 Q2 Form 10-Q Financial Statement

#000165495424006414 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED
PEDEVCO CORP Stock $ped